 |
|
Efficacy of the Antibiotics Chosen by ATS Guideline in the Treatment of Korean Patients with Community-acquired Pneumonia Admitted to a Tertiary Hospital.
Sung Yong Oh, Sang Joon Park, Young Min Koh, Gee Young Suh, Man Pyo Chung, Hojoong Kim, Dong Chull Choi, O Jung Kwon, Chong H Rhee
Tuberc Respir Dis. 1999;47(4):460-470. Published online 1999 Oct 1 DOI: https://doi.org/10.4046/trd.1999.47.4.460
|
|
Citations to this article as recorded by
 Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea
Min-Joo Choi, Shin-On Kang, Jin-Jeong Oh, Seong-Beom Park, Min-Ja Kim, Hee-Jin Cheong
Human Vaccines & Immunotherapeutics.2018; 14(8): 1914. CrossRef Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region
Jae-Hoon Song, Visanu Thamlikitkul, Po-Ren Hsueh
International Journal of Antimicrobial Agents.2011;[Epub] CrossRef
|